NASDAQ · BTSG
Healthcare · Medical - Healthcare Information Services
$63.35
Up+$0.70 (+1.12%)
Updated Oct 15, 2026, 4:18 AM
SID Score
5.8/10
Composite research score
Smart Money
58/100
Neutral
Price performance · BTSG
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
BTSG closed at $63.35 after 21 trading sessions, up 7.45% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $62.36 | $63.62 | $62.11 | $63.35 | 1.38M |
| Oct 13, 2026 | $62.82 | $63.3169 | $61.55 | $62.65 | 1.41M |
| Oct 12, 2026 | $63.65 | $64.23 | $62.10 | $63.01 | 1.52M |
| Oct 9, 2026 | $63.77 | $65.09 | $63.50 | $63.74 | 1.61M |
| Oct 8, 2026 | $63.74 | $64.535 | $62.62 | $63.66 | 2.22M |
| Oct 7, 2026 | $63.59 | $64.83 | $63.32 | $63.80 | 1.96M |
| Oct 6, 2026 | $62.97 | $65.64 | $62.97 | $63.75 | 3.12M |
| Oct 5, 2026 | $60.50 | $62.26 | $60.05 | $62.00 | 3.4M |
| Oct 2, 2026 | $58.23 | $60.43 | $57.95 | $60.25 | 3.2M |
| Oct 1, 2026 | $56.52 | $57.3899 | $55.9004 | $57.26 | 2.88M |
| Sep 30, 2026 | $55.87 | $56.86 | $55.12 | $56.75 | 2.16M |
| Sep 29, 2026 | $56.54 | $56.80 | $55.26 | $55.69 | 1.64M |
| Sep 28, 2026 | $56.08 | $57.69 | $55.975 | $56.54 | 2.03M |
| Sep 25, 2026 | $56.36 | $57.01 | $55.49 | $56.59 | 2.08M |
| Sep 24, 2026 | $55.54 | $56.42 | $54.87 | $56.02 | 2.43M |
| Sep 23, 2026 | $56.04 | $56.785 | $55.52 | $55.78 | 1.73M |
| Sep 22, 2026 | $56.10 | $57.05 | $55.815 | $56.55 | 2.08M |
| Sep 21, 2026 | $56.79 | $56.96 | $55.35 | $55.86 | 2.66M |
| Sep 18, 2026 | $56.235 | $57.51 | $55.64 | $56.78 | 9.36M |
| Sep 17, 2026 | $59.50 | $60.00 | $56.56 | $56.60 | 2.45M |
| Sep 16, 2026 | $59.35 | $60.00 | $58.79 | $58.96 | 1.65M |
The latest Smart Investors Daily articles mentioning BTSG.
Company
Market Activity
Research & News
BTSG research
Company profile and research snapshot.
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | BTIG | Buy | — |
| Aug 3, 2026 | BTIG | Buy | — |
| Jul 14, 2026 | Morgan Stanley | Overweight | — |
| Jul 14, 2026 | Keybanc | Overweight | — |
| Jul 13, 2026 | Wells Fargo | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 3, 2026
Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 4.8% in the afternoon session after BMO Capital analyst Sean Dodge reiterated an Outperform rating and a $70 price target on the company, StreetInsider reported.
Yahoo · Oct 1, 2026
LOUISVILLE, Ky., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its third quarter 2026 financial results on Friday, October 30, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on t
Yahoo · Sep 30, 2026
Option Care Health (OPCH) is back in focus after fresh commentary compared its home and alternate site infusion business with BrightSpring Health Services, highlighting how both could benefit as complex treatments continue shifting into lower cost home settings. Recent trading tells a mixed story. Option Care Health’s share price is up 8.41% over the past 90 days but down 29.25% year to date, while the 1 year total shareholder return has declined 17.83%, which may hint at fading momentum...
Yahoo · Sep 29, 2026
BrightSpring's faster growth, pharmacy and provider-service expansion, and improving margins contrast with OPCH's slower growth and chronic-therapy pressures.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BTSG.
